Literature DB >> 11668115

Use of cough swabs in a cystic fibrosis clinic.

A C Equi1, S E Pike, J Davies, A Bush.   

Abstract

We audited prospectively 322 cough swabs taken from cystic fibrosis children and compared cough swabs with concomitant sputum samples in 30 expectorating patients. A positive cough swab is a strong predictor of sputum culture. However, a negative cough swab does not rule out infection. Persistent symptoms should be further investigated.

Entities:  

Mesh：

Year:  2001        PMID： 11668115      PMCID： PMC1718986          DOI： 10.1136/adc.85.5.438

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN： 0003-9888            Impact factor:   3.791


  6 in total

1.  The flora of the respiratory tract of patients with cystic fibrosis of the pancreas.

Authors:  N N HUANG; E L VAN LOON; K T SHENG
Journal:  J Pediatr       Date:  1961-10       Impact factor: 4.406

2.  Diagnosing bacterial respiratory infection by bronchoalveolar lavage.

Authors:  F W Kahn; J M Jones
Journal:  J Infect Dis       Date:  1987-05       Impact factor: 5.226

3.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis.

Authors:  M Rosenfeld; J Emerson; F Accurso; D Armstrong; R Castile; K Grimwood; P Hiatt; K McCoy; S McNamara; B Ramsey; J Wagener
Journal:  Pediatr Pulmonol       Date:  1999-11

4.  Diagnostic tests. 1: Sensitivity and specificity.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1994-06-11

5.  Diagnostic tests 2: Predictive values.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1994-07-09

Review 6.  Diagnosis and treatment of cystic fibrosis.

Authors:  C Koch; N Høiby
Journal:  Respiration       Date:  2000       Impact factor: 3.580
  6 in total
  16 in total

1.  Cough plate versus cough swab in patients with cystic fibrosis; a pilot study.

Authors:  S Maiya; M Desai; A Baruah; P Weller; J R Clarke; J Gray
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

2.  Cough plates for microbiological surveillance in cystic fibrosis.

Authors:  Richard J Chavasse; Rebecca Cordle; Hawabibee Petkar
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

3.  Pseudomonas aeruginosa in the Cystic Fibrosis Lung.

Authors:  John King; Ronan Murphy; Jane C Davies
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

4.  Can throat swab after physiotherapy replace sputum for identification of microbial pathogens in children with cystic fibrosis?

Authors:  S K Kabra; Atul Alok; A Kapil; G Aggarwal; M Kabra; R Lodha; R M Pandey; K Sridevi; J Mathews
Journal:  Indian J Pediatr       Date:  2004-01       Impact factor: 1.967

Review 5.  The future of cystic fibrosis care: a global perspective.

Authors:  Scott C Bell; Marcus A Mall; Hector Gutierrez; Milan Macek; Susan Madge; Jane C Davies; Pierre-Régis Burgel; Elizabeth Tullis; Claudio Castaños; Carlo Castellani; Catherine A Byrnes; Fiona Cathcart; Sanjay H Chotirmall; Rebecca Cosgriff; Irmgard Eichler; Isabelle Fajac; Christopher H Goss; Pavel Drevinek; Philip M Farrell; Anna M Gravelle; Trudy Havermans; Nicole Mayer-Hamblett; Nataliya Kashirskaya; Eitan Kerem; Joseph L Mathew; Edward F McKone; Lutz Naehrlich; Samya Z Nasr; Gabriela R Oates; Ciaran O'Neill; Ulrike Pypops; Karen S Raraigh; Steven M Rowe; Kevin W Southern; Sheila Sivam; Anne L Stephenson; Marco Zampoli; Felix Ratjen
Journal:  Lancet Respir Med       Date:  2019-09-27       Impact factor: 30.700

Review 6.  Pseudomonas aeruginosa infection in patients with cystic fibrosis: scientific evidence regarding clinical impact, diagnosis, and treatment.

Authors:  Luiz Vicente Ribeiro Ferreira da Silva Filho; Flavia de Aguiar Ferreira; Francisco José Caldeira Reis; Murilo Carlos Amorim de Britto; Carlos Emilio Levy; Otavio Clark; José Dirceu Ribeiro
Journal:  J Bras Pneumol       Date:  2013 Jun-Aug       Impact factor: 2.624

7.  Assessment of IgG antibodies to Pseudomonas aeruginosa in patients with cystic fibrosis by an enzyme-linked immunosorbent assay (ELISA).

Authors:  Renan Marrichi Mauch; Cláudio Lúcio Rossi; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Marcos Tadeu Nolasco da Silva; Carlos Emílio Levy
Journal:  Diagn Pathol       Date:  2014-08-22       Impact factor: 2.644

8.  Microbial Etiology of Community-Acquired Pneumonia Among Infants and Children Admitted to the Pediatric Hospital, Ain Shams University.

Authors:  Magda Yehia El Seify; Eman Mahmoud Fouda; Hanan Mohamed Ibrahim; Maha Muhammad Fathy; Asmaa Al Husseiny Ahmed; Walaa Shawky Khater; Noha Nagi Mohammed Salah El Deen; Heba Galal Mohamed Abouzeid; Nancy Riyad Ahmed Hegazy; Heba Salah Sayed Elbanna
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2016-08-05

9.  Diagnostic and prognostic significance of systemic alkyl quinolones for P. aeruginosa in cystic fibrosis: A longitudinal study.

Authors:  Helen L Barr; Nigel Halliday; David A Barrett; Paul Williams; Douglas L Forrester; Daniel Peckham; Kate Williams; Alan R Smyth; David Honeybourne; Joanna L Whitehouse; Edward F Nash; Jane Dewar; Andrew Clayton; Alan J Knox; Miguel Cámara; Andrew W Fogarty
Journal:  J Cyst Fibros       Date:  2016-10-20       Impact factor: 5.482

10.  Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".

Authors:  Zhe Hui Hoo; Rachael Curley; Michael J Campbell; Stephen J Walters; Daniel Hind; Martin J Wildman
Journal:  Patient Prefer Adherence       Date:  2016-05-23       Impact factor: 2.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.